C19 - Multiple Sclerosis Overview I: Clinical Pearls
Event Time: | Saturday May 4, 2019 9:30 am to 11:30 am |
Topic(s): | MS and CNS Inflammatory Disease, Advanced Practice Provider |
Director(s): | Mary Willis MD, FAAN |
Description: | Diagnosis and treatment of multiple sclerosis and related disorders are getting more complex. Through a case-based approach, including common and uncommon scenarios, we will discuss issues related to diagnosis and treatment choices, including starting, monitoring, switching, and stopping disease modifying therapies. This program complements Multiple Sclerosis Overview II: Clinical Advances, but covers independent topics. |
Completion Message: | Participants should become more familiar with diagnosis and treatment of multiple sclerosis and related conditions, including use of recently approved therapies. |
CME Credits: | 2 |
Core Competencies: | Patient Care, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice |
Start/End Time | Title | Faculty |
---|---|---|
9:30 AM - 9:35 AM | Introduction | Mary Alissa Willis MD, FAAN |
9:35 AM - 10:10 AM | Diagnosis of Multiple Sclerosis | Mary Alissa Willis MD, FAAN |
10:10 AM - 10:50 AM | Treatment of Relapsing MS | Enrique Alvarez MD, PhD |
10:50 AM - 11:30 AM | Treatment of Progressive MS | Marisa P. McGinley DO |
Speaker | Disclosure |
---|---|
Enrique Alvarez, MD, PhD | Dr. Alvarez has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with consulting fees from Actelion, Bayer, Biogen, Celgene, EMD Serono, Genentech, Genzyme, Novartis, and TG Therapeutics. Dr. Alvarez has received research support from Biogen, Genentech, Novartis, TG Therapeutics, and Rocky Mountain MS Center. |
Marisa P. McGinley, DO | Dr. McGinley has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi Genzyme, and Genentech. Dr. McGinley has received research support from Novartis. |
Mary Alissa Willis, MD, FAAN | Dr. Willis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Genzyme, Novartis, Ipsen. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
9:15 AM-11:30 AM |
Neurology Year in Review Plenary Session
Martinson Arnan MD |
1:00 PM-3:00 PM |
S56 -
MS Trials and Treatment
|
3:30 PM-4:30 PM |
C257 -
Education Blitz: Evolution of Autoimmune Neurology
Steven Vernino MD, PhD, FAAN |
C258 -
Education Blitz: Multiple Sclerosis
Stephen Krieger MD, FAAN |